PL365463A1 - Leczenie zapalenia kości i stawów - Google Patents

Leczenie zapalenia kości i stawów

Info

Publication number
PL365463A1
PL365463A1 PL00365463A PL36546300A PL365463A1 PL 365463 A1 PL365463 A1 PL 365463A1 PL 00365463 A PL00365463 A PL 00365463A PL 36546300 A PL36546300 A PL 36546300A PL 365463 A1 PL365463 A1 PL 365463A1
Authority
PL
Poland
Prior art keywords
osteoarthritis
treatment
Prior art date
Application number
PL00365463A
Other languages
English (en)
Inventor
Carl M. Mendel
Timothy B. Seaton
Steven P. Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of PL365463A1 publication Critical patent/PL365463A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL00365463A 1999-03-19 2000-03-17 Leczenie zapalenia kości i stawów PL365463A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12530099P 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
PL365463A1 true PL365463A1 (pl) 2005-01-10

Family

ID=22419072

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00365463A PL365463A1 (pl) 1999-03-19 2000-03-17 Leczenie zapalenia kości i stawów

Country Status (20)

Country Link
EP (1) EP1169027A4 (pl)
JP (2) JP2002539248A (pl)
KR (1) KR20020038567A (pl)
CN (1) CN1352552A (pl)
AU (1) AU773490B2 (pl)
BG (1) BG105999A (pl)
BR (1) BR0009081A (pl)
CA (1) CA2366660A1 (pl)
CZ (1) CZ20013284A3 (pl)
HK (1) HK1044702A1 (pl)
HU (1) HUP0200494A2 (pl)
IL (1) IL145238A0 (pl)
MX (1) MXPA01009461A (pl)
NO (1) NO20014477L (pl)
NZ (1) NZ514016A (pl)
PL (1) PL365463A1 (pl)
SK (1) SK13342001A3 (pl)
TR (1) TR200102699T2 (pl)
WO (1) WO2000056306A1 (pl)
ZA (1) ZA200107682B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
ZA836848B (en) * 1982-09-30 1984-05-30 Boots Co Plc Therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
CA2138998A1 (en) * 1992-06-23 1994-01-06 James W. Young Methods and compositions for treating depression and other disorders using optically pure(-) sibutramine
CA2139000A1 (en) * 1992-06-23 1994-01-06 James W. Young Methods and compositions for treating depression and other disorders using optically pure(+) sibutramine
JP3862295B2 (ja) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
AU2764495A (en) * 1994-06-01 1995-12-21 Arris Pharmaceutical Corporation Compositions and methods for treating mast-cell mediated conditions
GB9619962D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .

Also Published As

Publication number Publication date
JP2012051904A (ja) 2012-03-15
AU773490B2 (en) 2004-05-27
MXPA01009461A (es) 2004-03-19
IL145238A0 (en) 2002-06-30
NO20014477D0 (no) 2001-09-14
JP2002539248A (ja) 2002-11-19
KR20020038567A (ko) 2002-05-23
CA2366660A1 (en) 2000-09-28
SK13342001A3 (sk) 2002-04-04
EP1169027A4 (en) 2004-10-20
NZ514016A (en) 2001-09-28
AU3893200A (en) 2000-10-09
NO20014477L (no) 2001-11-01
HUP0200494A2 (en) 2002-08-28
ZA200107682B (en) 2003-06-18
BG105999A (en) 2002-06-28
CZ20013284A3 (cs) 2002-10-16
HK1044702A1 (zh) 2002-11-01
TR200102699T2 (tr) 2002-03-21
BR0009081A (pt) 2003-03-05
EP1169027A1 (en) 2002-01-09
CN1352552A (zh) 2002-06-05
WO2000056306A1 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
GB2351661B (en) Novel method of treatment
EG22787A (en) Treatment of coal
IL145875A0 (en) Novel method of treatment
HUP0200157A3 (en) Treatment of infertility
GB9925136D0 (en) Novel treatment
IL144186A0 (en) Novel treatment
AU3896900A (en) Treatment of pain
NZ513686A (en) Treatment of trauma
GB0025103D0 (en) Treatment of process fluids
GB0205263D0 (en) Treatment of chemical hydrolysates
IL145238A0 (en) Treatment of osteoarthritis
IL149281A0 (en) Treatment of cancer
GB9930688D0 (en) Novel method of treatment
HUP0203741A3 (en) Treatment of osteoporosis
PL351081A1 (en) Treatment of hiatial hernia
EP1165060A4 (en) PROCESSING OF BILARIAL CALCULATIONS
GB9911183D0 (en) Treatment of cancers
GB9930696D0 (en) Novel method of treatment
GB9917181D0 (en) Methods of treatment
GB9901310D0 (en) Methods of treatment
GB9927005D0 (en) Treatment of cancers
GB9918534D0 (en) Treatment of cancers
GB9911346D0 (en) Treatment of cancers
GB9930689D0 (en) Novel method of treatment
GB9930692D0 (en) Novel method of treatment